Cancer Treatment Response

The “treatment response of a patient” is the medical term for whether a certain cancer therapy is yielding the desired beneficial results for the patient or not. It is in beneficial for all parties involved when this can be correctly predicted as soon as possible after the therapy has started.


It has been shown that “tissue permeability” can be a great indicator, or "biomarker", for determining if a cancer therapy is working or not. In short: aggressive growing tumoral tissue makes many “mistakes” in producing cells. This causes this tissue to have much higher blood leakage than healthy tissue.

Hyperfusion developed products that not only compares these biomarkers over time, but does so in a 100% automatic manner (*). Hyperfusion integrates into standard hospital infrastructure with reliable and fast processing in the cloud.